200 related articles for article (PubMed ID: 34509120)
1. Rationally designed short cationic α-helical peptides with selective anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
J Colloid Interface Sci; 2022 Feb; 607(Pt 1):488-501. PubMed ID: 34509120
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of rationally designed α-helical amphiphilic peptides.
Pan F; Li Y; Ding Y; Lv S; You R; Hadianamrei R; Tomeh MA; Zhao X
Colloids Surf B Biointerfaces; 2022 Dec; 220():112841. PubMed ID: 36174494
[TBL] [Abstract][Full Text] [Related]
4. Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity.
Chen C; Yang C; Chen Y; Wang F; Mu Q; Zhang J; Li Z; Pan F; Xu H; Lu JR
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26501-26510. PubMed ID: 27644109
[TBL] [Abstract][Full Text] [Related]
5. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
6. Rationally designed cationic amphiphilic peptides for selective gene delivery to cancer cells.
Hadianamrei R; Wang J; Brown S; Zhao X
Int J Pharm; 2022 Apr; 617():121619. PubMed ID: 35218898
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.
Kiyota T; Lee S; Sugihara G
Biochemistry; 1996 Oct; 35(40):13196-204. PubMed ID: 8855958
[TBL] [Abstract][Full Text] [Related]
8. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
[TBL] [Abstract][Full Text] [Related]
9. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
[TBL] [Abstract][Full Text] [Related]
10. Role of helicity on the anticancer mechanism of action of cationic-helical peptides.
Huang YB; He LY; Jiang HY; Chen YX
Int J Mol Sci; 2012; 13(6):6849-6862. PubMed ID: 22837667
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Anticancer Activity of Site Specific Short Chain Cationic Peptide.
Sharma RD; Jain J; Khosa RL
Curr Drug Discov Technol; 2020; 17(5):631-646. PubMed ID: 30947673
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.
Wiradharma N; Khoe U; Hauser CA; Seow SV; Zhang S; Yang YY
Biomaterials; 2011 Mar; 32(8):2204-12. PubMed ID: 21168911
[TBL] [Abstract][Full Text] [Related]
13. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
Raguse TL; Porter EA; Weisblum B; Gellman SH
J Am Chem Soc; 2002 Oct; 124(43):12774-85. PubMed ID: 12392424
[TBL] [Abstract][Full Text] [Related]
15. Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.
Rekdal Ø; Haug BE; Kalaaji M; Hunter HN; Lindin I; Israelsson I; Solstad T; Yang N; Brandl M; Mantzilas D; Vogel HJ
J Biol Chem; 2012 Jan; 287(1):233-244. PubMed ID: 22057278
[TBL] [Abstract][Full Text] [Related]
16. Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy.
Oren Z; Ramesh J; Avrahami D; Suryaprakash N; Shai Y; Jelinek R
Eur J Biochem; 2002 Aug; 269(16):3869-80. PubMed ID: 12180963
[TBL] [Abstract][Full Text] [Related]
17. Interaction of linear cationic peptides with phospholipid membranes and polymers of sialic acid.
Kuznetsov AS; Dubovskii PV; Vorontsova OV; Feofanov AV; Efremov RG
Biochemistry (Mosc); 2014 May; 79(5):459-68. PubMed ID: 24954597
[TBL] [Abstract][Full Text] [Related]
18. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
[TBL] [Abstract][Full Text] [Related]
19. Studies of the minimum hydrophobicity of alpha-helical peptides required to maintain a stable transmembrane association with phospholipid bilayer membranes.
Lewis RN; Liu F; Krivanek R; Rybar P; Hianik T; Flach CR; Mendelsohn R; Chen Y; Mant CT; Hodges RS; McElhaney RN
Biochemistry; 2007 Jan; 46(4):1042-54. PubMed ID: 17240988
[TBL] [Abstract][Full Text] [Related]
20. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework.
Huang YB; Wang XF; Wang HY; Liu Y; Chen Y
Mol Cancer Ther; 2011 Mar; 10(3):416-26. PubMed ID: 21252288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
